Table 2. Serum levels of IGF-1, IGFBP-4, and PAPP-A in treated and untreated patients with lung cancer and in the normal healthy control group.
Datas given as median and interquartile range, M, (Q1–Q3); TP; Treated patients, UTP; Untreated patients, *: different from control group, p<0.005
| Control (n=23) | TP (n=36) | UTP (n=24) | |
|---|---|---|---|
| IGF-1 (ng/mL) | 125, (101-140) | 141, (117-158.5) | 125, (90.3-151.5) |
| IGFBP-4 (ng/mL) | 104.6, (81.8-128.1) | 149.4*, (114.4-186.9) | 161.6*, (107.8-206.2) |
| PAPP-A (ng/mL) | 2.89, (1.84-4.39) | 2.7, (1.36-4.98) | 4.04, (2.31-5.84) |